2004Medical Journal of National Defending Forces in North ChinaRequires access

Clinical study on treatment of depression with Risperidone combined with Venlafaxine

Zhou Xiao

Open publisher page 1 citations

Abstract

Objective:To determine the clinical efficacy of Risperidone combined with Venlafaxine in treatment of depression.Methods:134 patients with depression diagnosed according to CCMD 3 were randomly assigned into two groups,one was treated with Venlafaxine alone and the other was with Risperidone combined with Venlafaxine for 9 weeks in order to evaluate the clinical efficacy and side effects with HAMD,HAMA and TESS after 2,4,6,9 weeks of the treatment.Results:There were significant differences in the decreased scores of HAMD,HAMA between the towo groups after 2,4,6 weeks of the treatment respectievely( P 0 01 AND P 0 05),wheras no difference was noted after 9 weeks.There was no difference in scores of TESS between the two groups after 2,4,6,9 weeks of treatment.Conclusions:Combination of Risperidone with Venlafaxine brought about a much better reponse than Venlafaxine alone.The advantages included: early response and fewer side effects.

About this research paper

What this paper is about

Objective:To determine the clinical efficacy of Risperidone combined with Venlafaxine in treatment of depression.Methods:134 patients with depression diagnosed according to CCMD 3 were randomly assigned into two groups,one was treated with Venlafaxine alone and the other was with Risperidone combined with Venlafaxine for 9 weeks in order to evaluate the clinical efficacy and side effects with HAMD,HAMA and TESS after 2,4,6,9 weeks of the treatment.Results:There were significant differences in the decreased scores of HAMD,HAMA between the towo groups after 2,4,6 weeks of the treatment respectievely( P 0 01 AND P 0 05),wheras no difference was noted after 9 weeks.There was no difference in scores of TESS between the two groups after 2,4,6,9 weeks of treatment.Conclusions:Combination of Risperidone with Venlafaxine brought about a much better reponse than Venlafaxine alone.The advantages included: early response and fewer side effects.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To determine the clinical efficacy of Risperidone combined with Venlafaxine in treatment of depression.Methods:134 patients with depression diagnosed according to CCMD 3 were randomly assigned into two groups,one was treated with Venlafaxine alone and the other was with Risperidone combined with Venlafaxine for 9 weeks in order to evaluate the clinical efficacy and side effects with HAMD,HAMA and TESS after 2,4,6,9 weeks of the treatment.Results:There were significant differences in the decreased scores of HAMD,HAMA between the towo groups after 2,4,6 weeks of the treatment respectievely( P 0 01 AND P 0 05),wheras no difference was noted after 9 weeks.There was no difference in scores of TESS between the two groups after 2,4,6,9 weeks of treatment.Conclusions:Combination of Risperidone with Venlafaxine brought about a much better reponse than Venlafaxine alone.The advantages included: early response and fewer side effects.

Key concepts: Venlafaxine, Risperidone, Hamd, Depression (economics), Medicine, Internal medicine, Clinical efficacy, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study on treatment of depression with Risperidone combined with Venlafaxine — Research Paper | ScholarLens